NCT02183038View on ClinicalTrials.gov

Efficacy and Safety of Meloxicam vs. Naproxen Sodium in Patients With Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis

PHASE2CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

February 28, 1999

Conditions
Pharyngitis
Interventions
DRUG

Meloxicam low

DRUG

Meloxicam high

DRUG

Naproxen sodium

DRUG

Meloxicam placebo low

DRUG

Meloxicam placebo high

DRUG

Naproxen sodium placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02183038 - Efficacy and Safety of Meloxicam vs. Naproxen Sodium in Patients With Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis | Biotech Hunter | Biotech Hunter